Bastiaan J. Tops
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Addressing the Global Diagnostics Gap for Childhood Leukemias: A Global, Multisite Type 2 Hybrid Validation Study of Nanopore-based Adaptive Sampling Whole Genome Sequencing.
Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2026
How 'Sturgeon' guides the surgeon in pediatric neuro-oncology.
Journal: Neuro-oncology
Published: February 10, 2026
Analytical Validation of an Annotation Tool for WGS-Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology.
Journal: Clinical and translational science
Published: October 31, 2025
Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade Osteosarcoma.
Journal: JCO precision oncology
Published: May 29, 2025
Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325].
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 13, 2025
Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?
Journal: Neuro-oncology
Published: April 10, 2025
Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.
Journal: The Journal of molecular diagnostics : JMD
Published: April 08, 2025
GLI1/2-altered mesenchymal tumors: a study of 8 cases expanding the clinicopathological and molecular spectrum including an upstream PTCH1-inactivating mutation.
Journal: Virchows Archiv : an international journal of pathology
Published: March 14, 2025
Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL.
Journal: JCO precision oncology
Published: February 28, 2025
Implementing Pre-Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects.
Journal: Clinical pharmacology and therapeutics
Published: January 06, 2025
VGLL fusions define a new class of intraparenchymal central nervous system schwannoma.
Journal: Neuro-oncology
Published: December 23, 2024
Last Updated: 09/26/2026